CMV reactivation in nonmyeloablative HSCT.
Graber
C
C
de Almeider
K N
KN
Childs
R
R
Barrett
A J
AJ
Gill
V J
VJ
Bennett
J E
JE
D016022:Case-Control Studies; D003587:Cytomegalovirus / Q000254:growth & development*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008212:Lymphocyte Depletion; D019653:Myeloablative Agonists / Q000627:therapeutic use; D012189:Retrospective Studies; D013601:T-Lymphocytes; D014775:Virus Activation
D019653:Myeloablative Agonists